Price data is not available

The average analyst price target for BioHarvest Sciences is $9, 432.5% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $5 to $14. The latest change came on Aug 12, 2026, when Maxim Group lowered its price target on BioHarvest Sciences from $12 to $5 and kept a Buy rating.
Price Target Range — 4 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months